Skip to content
Screener

CareDx CDNA Product revenue — Total Revenue

Other product segments

Testing services revenue
$91.4M+47.6%
Patient and digital solutions revenue
$15.96M+33.5%

Similar metrics at other companies

PTH
PTHSNet product revenues — Total Revenue
$10.67M—
Veracyte logo
VCYTProduct revenue — Total Revenue
$3.68M+2.8%
Idexx Laboratories logo
IDXXProduct revenue — Total Revenue
$666.12M+16.2%
XPEL, Inc. logo
XPELProduct revenue — Total Revenue
$111.67M+17.8%
Pacific Biosciences of California logo
PACBProduct revenue — Total Revenue
$32.95M-0.4%
Illumina logo
ILMNTotal product revenue — Total Revenue
$982M+7.7%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$2.32B+218%
Enterprise value$2.26B+228%
P/S5.6×+3.5×

Profitability

See full
Gross margin65.5%—
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: CareDx’s 10-Q, filed April 28, 2026.

Filed
Apr 28, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001217234-26-000033
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Revenue:
Testing services revenue$91,398$61,921
Product revenue10,34610,810
Patient and digital solutions revenue15,95611,954
Total revenue117,70084,685
Operating expenses:
Cost of testing services17,09715,113
Cost of product4,8345,586

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is CareDx's product revenue — total revenue?
CareDx (CDNA) reported product revenue — total revenue of $10.35M in Q1 2026.
How has CareDx's product revenue — total revenue changed year-over-year?
CareDx's product revenue — total revenue decreased by 4.3% year-over-year, from $10.81M to $10.35M.
What is the long-term trend for CareDx's product revenue — total revenue?
Over 4 years (2021 to 2025), CareDx's product revenue — total revenue has grown at a 15.9% compound annual growth rate (CAGR), from $26.83M to $48.38M.
What does product revenue — total revenue mean?
This metric represents the total gross revenue generated from the sale of specialized testing services, diagnostic products, and digital solutions tailored for transplant patients and clinical caregivers. It serves as a primary indicator of market adoption and commercial scale for the company's precision medicine portfolio. Tracking this revenue stream helps investors evaluate the company's ability to monetize its genomics-based information offerings within the transplant healthcare ecosystem.

Ask your AI about CareDx's product revenue — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude